Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

BackgroundThe emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in the treatment landscape of non-small cell lung cancer (NSCLC). Despite the promising long-term survival outcomes and optimization of pathological complete response (cPR) demonstrated by various studi...

Повний опис

Бібліографічні деталі

Автори:	Qin Wang, Chen Qi, Jing Luo, Nan Xu, Mao-tian Xu, Yong Qiang, Chi Zhang, Yi Shen
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-12-01
Серія:	Frontiers in Oncology
Предмети:	non-small cell lung cancer neoadjuvant therapy neoadjuvant immunotherapy neoadjuvant immunochemotherapy surgical-related safety
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1239451/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!